Cat. No. 4078
Chemical Name: 3,5-Dichlorobenzyl-[4-[3-oxo-3-(2-o
Biological ActivityPotent autotaxin inhibitor (IC50 = 2.8 nM in isolated enzyme assay; 101 nM in human whole blood). Modulates lysophosphatidic acid (LPA) levels in vivo and in vitro by directly inhibiting autotaxin; reduces LPA levels both in plasma and at site of inflammation. Orally available.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Jankowski (2011) Autotaxin: its role in biology of melanoma cells and as a pharmacological target. Enzyme Res. 194857. PMID: 21423677.
Gierse et al (2010) A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation. J.Pharmacol.Exp.Ther. 334 310. PMID: 20392816.
If you know of a relevant reference for PF 8380 please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses PF 8380 from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: PF 8380, supplier, PF8380, pfizer, autotaxin, lysophospholipase, d, inhibitors, lysophosphatidic, acid, LPA, inhibits, potent, Tocris Bioscience, Autotaxin Inhibitor products